Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. BGM
BGM logo

BGM Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
0.530
Open
0.509
VWAP
0.48
Vol
288.59K
Mkt Cap
104.32M
Low
0.450
Amount
139.47K
EV/EBITDA(TTM)
--
Total Shares
200.62M
EV
72.91M
EV/OCF(TTM)
--
P/S(TTM)
0.38
BGM Group Ltd, formerly Qilian International Holding Group Ltd, is a company mainly engaged in the development, manufacture, marketing and sale of licorice products, oxytetracycline products, traditional Chinese medicine derivatives (TCMD) product, heparin product, sausage casings and fertilizers. The Company operates through three segments: Oxytetracycline & Licorice Products and TCMD segment, Fertilizer segment and Heparin Products and Sausage Casing segment. The Company's main brand is Qilian Shan. The Company principally operates its businesses within the domestic market.
Show More

Events Timeline

(ET)
2026-02-26
17:30:00
BGM Group Warned by Nasdaq for Late Annual Report Filing
select
2025-05-02 (ET)
2025-05-02
08:32:18
BGM Group to acquire HM Management for $41.7M
select
2025-04-21 (ET)
2025-04-21
08:32:08
BGM Group acquires Wonder Dragon for RMB550M
select
2025-03-19 (ET)
2025-03-19
08:32:14
BGM Group to acquire YX Management Company for $95M
select
2025-02-28 (ET)
2025-02-28
08:32:17
BGM Group Chairman Zhanchang Xin resigns, Chen Xin to succeed
select
2025-02-19 (ET)
2025-02-19
07:40:36
BGM Group announces establishment of Duxiaobao Management Committee
select
2024-12-27 (ET)
2024-12-27
08:41:41
BGM Group completes acquisition of intelligent platform from AIX
select
2024-12-27
08:02:34
AIX completes share exchange with BGM Group
select
2024-11-29 (ET)
2024-11-29
08:02:29
BGM Group, AIX enter strategic transaction agreement
select
2024-10-29 (ET)
2024-10-29
08:02:52
Qilian International to change name to 'BGM Group Ltd.,' effective October 30
select

News

Benzinga
2.0
2025-12-17Benzinga
Toro, DBV Technologies, Udemy, ABM Industries, and Other Major Stocks Rising on Wednesday
  • U.S. Stock Market Performance: U.S. stocks showed mixed results, with the Dow Jones gaining over 150 points, while several companies, including Toro Co, reported better-than-expected quarterly earnings, leading to significant stock price increases.

  • Notable Stock Gains: Toro Co's shares rose 7% after reporting earnings of 91 cents per share, while DBV Technologies saw a 35.5% increase following positive trial results. Other companies like Udemy and Kodiak Sciences also experienced substantial gains.

  • Sector Highlights: Cannabis-related stocks surged after reports of potential reclassification of marijuana, with Canopy Growth Corp gaining 16.2%. Lithium-related stocks also rose following the cancellation of mining permits in Yichun.

  • Company Announcements and Upgrades: Several companies, including Recursion Pharmaceuticals and Two Harbors Investment Corp, saw stock price increases due to upgrades and acquisition announcements, reflecting positive investor sentiment.

Benzinga
2.0
2025-09-24Benzinga
Major Stocks Including Freeport-McMoRan, Harmony Biosciences, and Cohu Decline on Wednesday
  • U.S. Stock Market Performance: U.S. stocks declined, with the Dow Jones index dropping over 150 points, influenced by significant losses in various companies, particularly Freeport-McMoRan, which fell 16.4% after issuing disappointing sales guidance and reporting fatalities at its mine.

  • Notable Stock Declines: Other companies also experienced substantial losses, including Zhengye Biotechnology (-28.2%), Harmony Biosciences (-14.6%), and Cohu, Inc. (-12.7%), with Harmony's decline attributed to unmet clinical trial expectations and a lowered price target from Needham.

Benzinga
2.0
2025-09-17Benzinga
Major Stocks Including Lyft, Oruka Therapeutics, Roivant Sciences, and Workday Rise on Wednesday
  • U.S. Stock Market Performance: U.S. stocks showed mixed results, with the Dow Jones gaining over 200 points, while Lyft's shares surged 13.5% following a partnership with Waymo to manage autonomous vehicles in Nashville.

  • Notable Stock Gains: Several companies experienced significant stock increases, including New Fortress Energy (up 32.3%), Oruka Therapeutics (up 14.1%), and Workday (up 9%) after positive announcements and upgrades.

PRnewswire
9.5
2025-07-23PRnewswire
BGM To Report First Half 2025 Unaudited Financial Results on July 24, 2025
  • Financial Results Announcement: BGM Group will release its unaudited financial results for the first half of 2025 on July 24, 2025, before U.S. markets open.

  • Company Overview: BGM Group focuses on AI applications, intelligent robotics, algorithmic computing, cloud computing, and biopharmaceuticals, integrating AI into their production processes to enhance efficiency and provide customized services in various sectors.

Newsfilter
8.5
2025-05-28Newsfilter
From Virtual Agents to Embodied and Industry-Specific AI: BGM Acquires Xingdao Intelligent and YD Network, Advancing AI on Two Fronts
  • Acquisition Announcement: BGM Group Ltd. has entered into agreements to acquire 100% equity interests in Xingdao Intelligent Cloud Chain and YD Network for a combined valuation of RMB800 million, expected to close by the end of June 2025.

  • Strategic Expansion: The acquisitions aim to enhance BGM's AI capabilities in both robotics and fintech, allowing for deeper integration of hardware and software, and expanding its multi-agent AI productivity platform across various industries.

Benzinga
2.0
2025-05-25Benzinga
D-Wave Quantum And Advance Auto Parts Are Among Top 7 Mid-Cap Gainers Last Week (May 19-May 23): Are The Others In Your Portfolio?
  • Top Performing Mid-Cap Stocks: D-Wave Quantum Inc. saw a 53.47% increase after launching its Advantage2 quantum system, while Regencell Bioscience Holdings and Advance Auto Parts also experienced significant gains of 42.49% and 38.94%, respectively, following positive company announcements.

  • Other Notable Stock Increases: Merus N.V. rose by 32.68% due to promising clinical trial data, Oklo Inc. gained 29.56% amid regulatory easing reports, and several other mid-cap stocks like Sibanye-Stillwater Limited and BGM Group Ltd. also showed strong performance last week.

Valuation Metrics

The current forward P/E ratio for BGM Group Ltd (BGM.O) is 0.00, compared to its 5-year average forward P/E of 0.00. For a more detailed relative valuation and DCF analysis to assess BGM Group Ltd's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
0.00
Current PE
0.00
Overvalued PE
0.00
Undervalued PE
0.00

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
0.00
Undervalued EV/EBITDA
0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
0.00
Current PS
0.00
Overvalued PS
0.00
Undervalued PS
0.00

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

what is the best penny stock for tomorrow
Intellectia · 72 candidates
Market Cap: >= 50.00MPrice: $0.10 - $5.00List Exchange: XNYS, XNAS, XASEMoving Average Relationship: PriceAboveMA20One Day Rise Prob: >= 60One Day Predict Return: >= 0.0%
Ticker
Name
Market Cap$
top bottom
LU logo
LU
Lufax Holding Ltd
2.31B
AMTX logo
AMTX
Aemetis Inc
98.64M
BLNK logo
BLNK
Blink Charging Co
117.51M
IOVA logo
IOVA
Iovance Biotherapeutics Inc
996.39M
BBD logo
BBD
Banco Bradesco SA
39.45B
WWR logo
WWR
Westwater Resources Inc
126.25M

Whales Holding BGM

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is BGM Group Ltd (BGM) stock price today?

The current price of BGM is 0.4698 USD — it has decreased -9.62

What is BGM Group Ltd (BGM)'s business?

BGM Group Ltd, formerly Qilian International Holding Group Ltd, is a company mainly engaged in the development, manufacture, marketing and sale of licorice products, oxytetracycline products, traditional Chinese medicine derivatives (TCMD) product, heparin product, sausage casings and fertilizers. The Company operates through three segments: Oxytetracycline & Licorice Products and TCMD segment, Fertilizer segment and Heparin Products and Sausage Casing segment. The Company's main brand is Qilian Shan. The Company principally operates its businesses within the domestic market.

What is the price predicton of BGM Stock?

Wall Street analysts forecast BGM stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for BGM is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is BGM Group Ltd (BGM)'s revenue for the last quarter?

BGM Group Ltd revenue for the last quarter amounts to NaN USD, decreased

What is BGM Group Ltd (BGM)'s earnings per share (EPS) for the last quarter?

BGM Group Ltd. EPS for the last quarter amounts to USD, decreased

How many employees does BGM Group Ltd (BGM). have?

BGM Group Ltd (BGM) has 323 emplpoyees as of March 28 2026.

What is BGM Group Ltd (BGM) market cap?

Today BGM has the market capitalization of 104.32M USD.